C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2007
01/03/2007	CN1293076C Activator for peroxisome proliferator-activated receptor delta
01/03/2007	CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands
01/03/2007	CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
01/03/2007	CN1293059C New Carboxglic acid derivative, its preparation and application
01/03/2007	CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
01/02/2007	US7157587 Imide-extended liquid bismaleimide resin
01/02/2007	US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
01/02/2007	US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents
01/02/2007	US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
01/02/2007	US7157577 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
01/02/2007	US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/02/2007	US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders
01/02/2007	US7157487 Vla-4 inhibitors
01/02/2007	US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007	US7157468 Pyrazole derivatives
01/02/2007	US7157464 Substituted piperazines
01/02/2007	US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists
01/02/2007	US7157462 Therapeutic agents useful for treating pain
01/02/2007	US7157461 For therapy of hypertension
01/02/2007	US7157455 4-Aminopyrimidine-5-one derivatives
01/02/2007	US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
12/2006
12/28/2006	WO2006138304A2 Pyrimidine compounds
12/28/2006	WO2006138180A1 Tubulin inhibitor and process for its preparation
12/28/2006	WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006	WO2006137790A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006	WO2006137421A1 Agent for topical administration
12/28/2006	WO2006137083A1 Improved process for the preparation of rizatriptan benzoate
12/28/2006	WO2006136924A1 Histamine-3 receptor antagonists
12/28/2006	WO2006136857A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors
12/28/2006	WO2006136821A1 Pharmaceutical compounds
12/28/2006	WO2006136606A2 Oxindole derivatives
12/28/2006	WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
12/28/2006	WO2006136223A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/28/2006	WO2006135973A1 Small molecule glycosaminoglycan mimetics
12/28/2006	WO2006122014A3 Bicyclic derivatives as modulators of ion channels
12/28/2006	WO2006101521A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/28/2006	WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
12/28/2006	WO2006055463A3 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
12/28/2006	WO2005104711A3 Purification of progesterone receptor modulators
12/28/2006	WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2006	US20060293520 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils
12/28/2006	US20060293377 Amorphous and polymorphic forms of telmisartan sodium
12/28/2006	US20060293363 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
12/28/2006	US20060293362 Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
12/28/2006	US20060293354 Pyrimidine derivatives and their use as CB2 modulators
12/28/2006	US20060293353 Matrix metalloproteinase inhibitors
12/28/2006	US20060293349 5-Chloro-4-alkyl-3,4-dihydro-quinazolin-2-ylamine derivatives
12/28/2006	US20060293347 Pharmaceutically active compounds
12/28/2006	US20060293343 Pyrimidine derivatives
12/28/2006	US20060293340 2-Aminopyrimidine derivatives as raf kinase inhibitors
12/28/2006	US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers
12/28/2006	US20060293337 P2x7 receptor antagonists and their use
12/28/2006	US20060293336 C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/28/2006	US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/28/2006	US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006	US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006	US20060293324 Pyrimidine compounds
12/28/2006	US20060293319 Oxindole derivatives
12/28/2006	US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents
12/28/2006	US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
12/28/2006	US20060293311 Compositions and methods for inhibition of the jak pathway
12/28/2006	US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme
12/28/2006	US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006	US20060293303 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry
12/28/2006	US20060293299 3-((1S)-1-{1-[(S)-(3-cyanophenyl)(4-cyanophenyl)methyl]azetidin-3-yl}-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile and its salts; antagonists and inverse agonists of the Cannabinoid-1 receptor
12/28/2006	US20060293297 Cyanofluoropyrrolidine derviative
12/28/2006	US20060293289 Moderator of neurotransmitters releasing; analgesics ; central nervous system disorders; using N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine
12/28/2006	US20060293281 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/28/2006	US20060292658 Fluorescent compound
12/28/2006	DE102006023178A1 New solid crystalline telmisartan form A useful for preparation of pharmaceutical composition for treatment of hypertension
12/28/2006	CA2612451A1 Oxindole derivatives
12/28/2006	CA2612227A1 Pyrimidine compounds
12/28/2006	CA2612133A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006	CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
12/28/2006	CA2610416A1 Tubulin inhibitor and process for its preparation
12/27/2006	EP1736472A1 2-aminopyridine derivative
12/27/2006	EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
12/27/2006	EP1736465A1 Aniline derivatives
12/27/2006	EP1735319A1 Inhibitors of histone deacetylase
12/27/2006	EP1735307A1 Inhibitors of iap
12/27/2006	EP1735299A1 Tertrahydrobenzazepines as histamine h3 receptor ligands
12/27/2006	EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/27/2006	EP1735286A1 Tetrahydro-indazole cannabinoid modulators
12/27/2006	EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
12/27/2006	EP1735282A1 Pyrazole compounds and uses related thereto
12/27/2006	EP1735279A1 Prolinyl derivates for treating thrombosis
12/27/2006	EP1735278A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/27/2006	EP1660485B1 Improved process for preparing alpha-polymorphic eletriptan hydrobromide
12/27/2006	EP1608317A4 Dipeptidyl peptidase inhibitors
12/27/2006	EP1554259B1 Novel bicyclic inhibitors of hormone sensitive lipase
12/27/2006	EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors
12/27/2006	EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006	CN1886421A Hemiasterlin derivatives and uses thereof
12/27/2006	CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
12/27/2006	CN1886399A 喹唑啉衍生物 Quinazoline derivatives
12/27/2006	CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
12/27/2006	CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease
12/27/2006	CN1886389A 喹喔啉化合物 Quinoxaline compounds
12/27/2006	CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
12/27/2006	CN1886380A Benzoimidazole compounds

1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 626